Mitomycin

An inhibitor of topoisomerase I that demonstrates less toxicity than its parent compound demonstrates strong anti-tumor activity against a wide range of experimental tumors including L1210 leukemia cells (IC₅₀ = 1.15 &muM).

An inhibitor of topoisomerase I that demonstrates less toxicity than its parent compound demonstrates strong anti-tumor activity against a wide range of experimental tumors including L1210 leukemia cells (IC₅₀ = 1.15 &muM).

An inhibitor of topoisomerase I that demonstrates less toxicity than its parent compound demonstrates strong anti-tumor activity against a wide range of experimental tumors including L1210 leukemia cells (IC₅₀ = 1.15 &muM).

An inhibitor of topoisomerase I that demonstrates less toxicity than its parent compound demonstrates strong anti-tumor activity against a wide range of experimental tumors including L1210 leukemia cells (IC₅₀ = 1.15 &muM).

A camptothecin derivative that inhibits DNA topoisomerase I.

A camptothecin derivative that inhibits DNA topoisomerase I.

A camptothecin derivative that inhibits DNA topoisomerase I.

A camptothecin derivative that inhibits DNA topoisomerase I.

A camptothecin derivative that inhibits DNA topoisomerase I.

10-Methoxycamptothecin is a natural bioactive derivative of camptothecin (CPT) isolated from Camptotheca acuminata, and has been confirmed to possess high anti-cancer properties. 10-Methoxycamptothecin has higher cytotoxicity than

10-Methoxycamptothecin is a natural bioactive derivative of camptothecin (CPT) isolated from Camptotheca acuminata, and has been confirmed to possess high anti-cancer properties. 10-Methoxycamptothecin has higher cytotoxicity than

10-Methoxycamptothecin is a natural bioactive derivative of camptothecin (CPT) isolated from Camptotheca acuminata, and has been confirmed to possess high anti-cancer properties. 10-Methoxycamptothecin has higher cytotoxicity than